MetaADEDB 2.0 @ LMMD
haloperidol decanoate
(GUTXTARXLVFHDK-UHFFFAOYSA-N)
Structure
SMILES
CCCCCCCCCC(=O)OC1(CCN(CC1)CCCC(=O)c1ccc(cc1)F)c1ccc(cc1)Cl
Molecular Formula:
C31H41ClFNO3
Molecular Weight:
530.114
Log P:
8.0551
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
0
TPSA:
46.61
CAS Number(s):
74050-97-8
Synonym(s)
1.
haloperidol decanoate
External Link(s)
MeSHC033563
PubChem Compound52919
BindingDB50053408
ChEBI31664
CHEMBLCHEMBL1200986
DrugCentral4496
KEGGdr:D01898
ZINC8214574
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug dose omissionFAERS: 51US FAERS
2Drug ineffectiveFAERS: 26US FAERS
3Product quality issueFAERS: 24US FAERS
4Accidental exposure to productFAERS: 22US FAERS
5OverdoseFAERS: 17OFFSIDES
US FAERS
6Inappropriate schedule of drug administrationFAERS: 15OFFSIDES
US FAERS
7Product container issueFAERS: 15US FAERS
8Incorrect route of drug administrationFAERS: 14OFFSIDES
US FAERS
9Medication ErrorFAERS: 14US FAERS
10Tardive DyskinesiaFAERS: 14OFFSIDES
US FAERS
11Adverse eventFAERS: 13US FAERS
12AkathisiaFAERS: 12US FAERS
13TremorFAERS: 12US FAERS
14Incorrect dose administeredFAERS: 11US FAERS
15Neuroleptic Malignant SyndromeFAERS: 119053957
9734560
CTD
OFFSIDES
US FAERS
16LacerationFAERS: 9US FAERS
17Drug administration errorFAERS: 8OFFSIDES
US FAERS
18Injection site erythemaFAERS: 8US FAERS
19Product use issueFAERS: 8US FAERS
20SomnolenceFAERS: 8US FAERS
21AgitationFAERS: 7US FAERS
22Diabetes MellitusFAERS: 7US FAERS
23Injection Site ReactionFAERS: 7US FAERS
24Injection site painFAERS: 7US FAERS
25MalaiseFAERS: 7US FAERS
26AnxietyFAERS: 6US FAERS
27Product physical consistency issueFAERS: 6US FAERS
28Atrial FibrillationFAERS: 5US FAERS
29Drug administered at inappropriate siteFAERS: 5US FAERS
30Erectile dysfunctionFAERS: 5US FAERS
31Injection site abscessFAERS: 5US FAERS
32Memory impairmentFAERS: 5US FAERS
33RestlessnessFAERS: 5US FAERS
34VomitingFAERS: 5US FAERS
35Weight decreasedFAERS: 5US FAERS
36Wrong technique in product usage processFAERS: 5US FAERS
37Device malfunctionFAERS: 4US FAERS
38DizzinessFAERS: 4US FAERS
39DroolingFAERS: 4US FAERS
40Drug exposure during pregnancyFAERS: 4US FAERS
41Drug level below therapeuticFAERS: 4OFFSIDES
US FAERS
42DystoniaFAERS: 49734560
19014097
CTD
US FAERS
43FatigueFAERS: 4US FAERS
44HypotensionFAERS: 4US FAERS
45Injection site massFAERS: 4US FAERS
46Intentional product use issueFAERS: 4US FAERS
47Product leakageFAERS: 4US FAERS
48Product measured potency issueFAERS: 4US FAERS
49Product packaging quantity issueFAERS: 4US FAERS
50Pulmonary EmbolismFAERS: 4US FAERS
51TachycardiaFAERS: 4US FAERS
52Toxicity to various agentsFAERS: 4US FAERS
53ArthritisFAERS: 3US FAERS
54Blood creatine phosphokinase increasedFAERS: 3US FAERS
55BradycardiaFAERS: 3US FAERS
56Cerebrovascular accidentFAERS: 3US FAERS
57Deep Vein ThrombosisFAERS: 3US FAERS
58DeliriumFAERS: 3US FAERS
59Drug prescribing errorFAERS: 3OFFSIDES
US FAERS
60Expired product administeredFAERS: 3US FAERS
61Feeling abnormalFAERS: 3US FAERS
62HypersensitivityFAERS: 3US FAERS
63Inappropriate schedule of product administrationFAERS: 3US FAERS
64Injection site infectionFAERS: 3US FAERS
65Intentional drug misuseFAERS: 3OFFSIDES
US FAERS
66Metabolic acidosisFAERS: 3US FAERS
67Muscle RigidityFAERS: 3US FAERS
68Myocardial InfarctionFAERS: 3US FAERS
69PainFAERS: 3US FAERS
70Pharmaceutical product complaintFAERS: 3US FAERS
71Product availability issueFAERS: 3US FAERS
72Product package associated injuryFAERS: 3US FAERS
73SchizophreniaFAERS: 3

View details

CTD
US FAERS
74Sexual DysfunctionFAERS: 3US FAERS
75Suicide attemptFAERS: 3US FAERS
76ThrombocytopeniaFAERS: 3US FAERS
77TorticollisFAERS: 3US FAERS
78Visual ImpairmentFAERS: 3US FAERS
79Accidental overdoseFAERS: 2OFFSIDES
US FAERS
80Acute psychosisFAERS: 2US FAERS
81AmnesiaFAERS: 2US FAERS
82AngerFAERS: 2US FAERS
83AngioedemaFAERS: 2US FAERS
84AnorexiaFAERS: 2US FAERS
85AphasiaFAERS: 2US FAERS
86AstheniaFAERS: 2US FAERS
87BedriddenFAERS: 2US FAERS
88Bronchial secretion retentionFAERS: 2OFFSIDES
US FAERS
89CatatoniaFAERS: 214770062CTD
OFFSIDES
US FAERS
90ConstipationFAERS: 2US FAERS
91DehydrationFAERS: 2US FAERS
92Dependent Personality DisorderFAERS: 2US FAERS
93Depression suicidalFAERS: 2US FAERS
94DiscomfortFAERS: 2US FAERS
95Drug DependenceFAERS: 2US FAERS
96Drug dispensing errorFAERS: 2OFFSIDES
US FAERS
97Drug effect incompleteFAERS: 2US FAERS
98Drug level decreasedFAERS: 2US FAERS
99Drug toxicityFAERS: 2US FAERS
100DysarthriaFAERS: 2US FAERS
101DysphoniaFAERS: 2US FAERS
102EpilepsyFAERS: 2US FAERS
103EpistaxisFAERS: 2US FAERS
104Exposure to unspecified agentFAERS: 2US FAERS
105ExtravasationFAERS: 2US FAERS
106Gaze palsyFAERS: 2OFFSIDES
US FAERS
107HypersomniaFAERS: 2US FAERS
108HypokinesiaFAERS: 2OFFSIDES
US FAERS
109Incorrect product storageFAERS: 2US FAERS
110Incorrect route of product administrationFAERS: 2US FAERS
111InflammationFAERS: 2US FAERS
112Injection site noduleFAERS: 2US FAERS
113Injection site thrombosisFAERS: 2US FAERS
114Intentional self-injuryFAERS: 2US FAERS
115Morbid thoughtsFAERS: 2OFFSIDES
US FAERS
116Musculoskeletal PainFAERS: 2US FAERS
117Musculoskeletal stiffnessFAERS: 2US FAERS
118MyoclonusFAERS: 2US FAERS
119Needle issueFAERS: 2US FAERS
120Negative thoughtsFAERS: 2US FAERS
121NeutropeniaFAERS: 2US FAERS
122Oculogyric crisisFAERS: 2US FAERS
123Product dose omissionFAERS: 2US FAERS
124Product label issueFAERS: 2US FAERS
125Product packaging issueFAERS: 2US FAERS
126Product storage errorFAERS: 2US FAERS
127Psychiatric symptomFAERS: 2US FAERS
128Respiratory arrestFAERS: 2US FAERS
129SacroiliitisFAERS: 2OFFSIDES
US FAERS
130SoporFAERS: 2US FAERS
131TrismusFAERS: 2US FAERS
132Unevaluable eventFAERS: 2US FAERS
133Urinary IncontinenceFAERS: 2US FAERS
134Urinary RetentionFAERS: 2US FAERS
135Urinary tract infectionFAERS: 2US FAERS
136Wrong drug administeredFAERS: 2OFFSIDES
US FAERS
137Wrong technique in drug usage processFAERS: 2US FAERS
138Abdominal discomfortFAERS: 1US FAERS
139Activities of daily living impairedFAERS: 1US FAERS
140AgranulocytosisFAERS: 1US FAERS
141Alanine aminotransferase abnormalFAERS: 1US FAERS
142Alcohol abuseFAERS: 1US FAERS
143Angina PectorisFAERS: 1US FAERS
144AppendicitisFAERS: 1US FAERS
145Application site irritationFAERS: 1US FAERS
146Autonomic nervous system imbalanceFAERS: 1US FAERS
147Bipolar DisorderFAERS: 1US FAERS
148BlepharospasmFAERS: 1US FAERS
149Blood bilirubin abnormalFAERS: 1US FAERS
150BradykinesiaFAERS: 1US FAERS
151BradyphreniaFAERS: 1US FAERS
152BronchospasmFAERS: 1US FAERS
153CHARGE SyndromeFAERS: 1US FAERS
154CellulitisFAERS: 1US FAERS
155Cerebral InfarctionFAERS: 1US FAERS
156Chest PainFAERS: 1US FAERS
157CholestasisFAERS: 1US FAERS
158Cold sweatFAERS: 1US FAERS
159Completed SuicideFAERS: 1US FAERS
160DeafnessFAERS: 1US FAERS
161DeformityFAERS: 1US FAERS
162DementiaFAERS: 1US FAERS
163Dental discomfortFAERS: 1US FAERS
164Device breakageFAERS: 1US FAERS
165Device damageFAERS: 1US FAERS
166DisabilityFAERS: 1US FAERS
167DissociationFAERS: 1US FAERS
168Drug level increasedFAERS: 1US FAERS
169DysgraphiaFAERS: 1US FAERS
170DyspepsiaFAERS: 1US FAERS
171Electrocardiogram changeFAERS: 1US FAERS
172Emotional distressFAERS: 1US FAERS
173Eyelid Function DisorderFAERS: 1US FAERS
174Feeling jitteryFAERS: 1US FAERS
175FractureFAERS: 1US FAERS
176General physical condition abnormalFAERS: 1US FAERS
177General physical health deteriorationFAERS: 1US FAERS
178GlaucomaFAERS: 1US FAERS
179HeadacheFAERS: 1US FAERS
180Hepatitis CFAERS: 1US FAERS
181HepatotoxicityFAERS: 1US FAERS
182HomicideFAERS: 1US FAERS
183HyperpyrexiaFAERS: 1US FAERS
184HyperthyroidismFAERS: 1US FAERS
185HypospermiaFAERS: 1US FAERS
186HypoventilationFAERS: 1US FAERS
187Impaired driving abilityFAERS: 1US FAERS
188ImpatienceFAERS: 1US FAERS
189IncoherentFAERS: 1US FAERS
190IndurationFAERS: 1US FAERS
191InfertilityFAERS: 1US FAERS
192Injection site cellulitisFAERS: 1OFFSIDES
US FAERS
193Injection site discomfortFAERS: 1US FAERS
194Injection site extravasationFAERS: 1US FAERS
195Injection site ulcerFAERS: 1US FAERS
196Injection site urticariaFAERS: 1US FAERS
197Injection site warmthFAERS: 1US FAERS
198Injury associated with deviceFAERS: 1US FAERS
199Intercepted medication errorFAERS: 1US FAERS
200Joint swellingFAERS: 1US FAERS
201Late metabolic acidosis of newbornFAERS: 1US FAERS
202Left atrial hypertrophyFAERS: 1US FAERS
203Lip swellingFAERS: 1US FAERS
204Mental status changesFAERS: 1OFFSIDES
US FAERS
205Mood swingsFAERS: 1US FAERS
206Muscle strainFAERS: 1US FAERS
207Muscle tightnessFAERS: 1US FAERS
208MutismFAERS: 1OFFSIDES
US FAERS
209MyalgiaFAERS: 1US FAERS
210MyocarditisFAERS: 1US FAERS
211MyopiaFAERS: 1US FAERS
212MyositisFAERS: 1US FAERS
213NecrospermiaFAERS: 1US FAERS
214Nipple painFAERS: 1US FAERS
215NoduleFAERS: 1US FAERS
216ObesityFAERS: 1US FAERS
217OligospermiaFAERS: 1US FAERS
218Oromandibular dystoniaFAERS: 1US FAERS
219Oropharyngeal spasmFAERS: 1OFFSIDES
US FAERS
220PallorFAERS: 1US FAERS
221PalpitationsFAERS: 1US FAERS
222PancytopeniaFAERS: 1US FAERS
223PhotophobiaFAERS: 1US FAERS
224Physical assaultFAERS: 1US FAERS
225PleurisyFAERS: 1US FAERS
226PneumoniaFAERS: 1US FAERS
227Poor quality drug administeredFAERS: 1US FAERS
228PregnancyFAERS: 1US FAERS
229Prescribed overdoseFAERS: 1US FAERS
230Pressure of speechFAERS: 1US FAERS
231Product closure removal difficultFAERS: 1US FAERS
232Product complaintFAERS: 1US FAERS
233Product contamination physicalFAERS: 1US FAERS
234Product lot number issueFAERS: 1US FAERS
235Product name confusionFAERS: 1US FAERS
236Product outer packaging issueFAERS: 1US FAERS
237Product physical issueFAERS: 1US FAERS
238Product use in unapproved indicationFAERS: 1US FAERS
239PruritusFAERS: 1US FAERS
240Psychiatric decompensationFAERS: 1US FAERS
241Pulmonary artery thrombosisFAERS: 1US FAERS
242Rabbit syndromeFAERS: 1US FAERS
243Rash erythematousFAERS: 1US FAERS
244Reaction to drug excipientsFAERS: 1US FAERS
245Retroperitoneal fibrosisFAERS: 1OFFSIDES
US FAERS
246Self MutilationFAERS: 1US FAERS
247Septic ShockFAERS: 1US FAERS
248SluggishnessFAERS: 1US FAERS
249Sudden deathFAERS: 1OFFSIDES
US FAERS
250Superficial injury of eyeFAERS: 1US FAERS
251Therapeutic product effect decreasedFAERS: 1US FAERS
252Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
253Therapy changeFAERS: 1US FAERS
254Thirst decreasedFAERS: 1US FAERS
255ThrombosisFAERS: 1US FAERS
256Tongue spasmFAERS: 1US FAERS
257Traumatic Brain InjuryFAERS: 1US FAERS
258Unresponsive to stimuliFAERS: 1US FAERS
259UveitisFAERS: 1US FAERS
260VIIth nerve paralysisFAERS: 1US FAERS
261Venous thrombosis limbFAERS: 1OFFSIDES
US FAERS
262VertigoFAERS: 1US FAERS
263VitiligoFAERS: 1US FAERS
264Wrong dosage formFAERS: 1US FAERS
265AbscessOFFSIDES
266Acute kidney injury9053957CTD
267Anticonvulsant drug level decreasedOFFSIDES
268Antipsychotic drug level below therapeuticOFFSIDES
269ApneaOFFSIDES
270Aspiration PneumoniaOFFSIDES
271Cardiac HypertrophyOFFSIDES
272Catalepsy7617800
8535858
CTD
273Chemotherapeutic drug level increasedOFFSIDES
274Cholestatic liver injuryOFFSIDES
275Circumstance or information capable of leading to medication errorOFFSIDES
276CyanosisOFFSIDES
277Disseminated Intravascular CoagulationOFFSIDES
278Dyskinesia, Drug-Induced

View details

CTD
279ExophthalmosOFFSIDES
280Feeding disorder neonatalOFFSIDES
281Gynecomastia17873694CTD
282Hallucinations18583682CTD
283Hyperprolactinemia17873694CTD
284HypomaniaOFFSIDES
285HypophagiaOFFSIDES
286HyporeflexiaOFFSIDES
287Intraocular inflammationOFFSIDES
288Left Ventricular HypertrophyOFFSIDES
289Mood Disorders1362688CTD
290Movement Disorders7912473
10548281
17873695
CTD
291OculogyrationOFFSIDES
292PROTHROMBIN TIMEOFFSIDES
293Procedural complicationOFFSIDES
294Psychotic Disorders9734560CTD
295Pulmonary InfarctionOFFSIDES
296Renal salt-wasting syndromeOFFSIDES
297Rhabdomyolysis9053957CTD
OFFSIDES
298Risus sardonicusOFFSIDES
299Status EpilepticusOFFSIDES
300Sudden Cardiac DeathOFFSIDES
301Transaminases increasedOFFSIDES
302Urine ketone body presentOFFSIDES
303Urobilin urine presentOFFSIDES
304Ventricular FibrillationOFFSIDES
305Water IntoxicationOFFSIDES
306Weight GainOFFSIDES
307XanthomaOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.